表紙:スマートピルズのドラッグデリバリー市場規模、シェア、成長分析、タイプ別、コンポーネント別、用途別、エンドユーザー別、適応疾患別、地域別 - 産業予測、2025年~2032年
市場調査レポート
商品コード
1770762

スマートピルズのドラッグデリバリー市場規模、シェア、成長分析、タイプ別、コンポーネント別、用途別、エンドユーザー別、適応疾患別、地域別 - 産業予測、2025年~2032年

Smart Pills Drug Delivery Market Size, Share, and Growth Analysis, By Type, By Component, By Application, By End User, By Disease Indication, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 197 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
スマートピルズのドラッグデリバリー市場規模、シェア、成長分析、タイプ別、コンポーネント別、用途別、エンドユーザー別、適応疾患別、地域別 - 産業予測、2025年~2032年
出版日: 2025年07月08日
発行: SkyQuest
ページ情報: 英文 197 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

スマートピルズのドラッグデリバリーの世界市場規模は2023年に21億米ドルと評価され、2024年の23億2,000万米ドルから2032年には51億6,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは10.5%で成長する見通しです。

スマートピルズのドラッグデリバリー市場は、継続的なモニタリングと治療を必要とする大腸がんや糖尿病などの消化器疾患や慢性疾患の有病率の上昇に牽引されて成長を遂げています。患者はより侵襲性の低い診断方法を好むようになっており、スマートピルが従来の選択肢に代わる魅力的な選択肢となっています。高精細画像や無線データ伝送を含む内視鏡技術の革新は、これらの摂取可能な装置の性能を向上させています。さらに、患者の遠隔モニタリングへのシフトがスマートピルの需要を支えており、コンプライアンスとバイタルサインを効果的に追跡して臨床転帰を改善しています。しかし、高額なデバイス費用、限られた償還、規制上のハードル、データセキュリティやデバイスの信頼性に関する懸念などの課題が、特に長期的な用途での市場導入を妨げる可能性があります。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術分析
  • ケーススタディ

スマートピルズのドラッグデリバリー市場規模:タイプ別& CAGR(2025-2032)

  • 市場概要
  • カプセル内視鏡検査
  • 患者モニタリングスマートピル
  • 薬剤送達スマートピル

スマートピルズのドラッグデリバリー市場規模:コンポーネント別& CAGR(2025-2032)

  • 市場概要
  • 摂取可能なセンサー
  • ウェアラブル受信機/パッチ
  • ソフトウェアと分析プラットフォーム

スマートピルズのドラッグデリバリー市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 診断画像
  • 服薬遵守追跡
  • 標的ドラッグデリバリー

スマートピルズのドラッグデリバリー市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 病院と診療所
  • 診断センター
  • 在宅ヘルスケア
  • 調査機関

スマートピルズのドラッグデリバリー市場規模:適応疾患別& CAGR(2025-2032)

  • 市場概要
  • 胃腸障害
  • 腫瘍学
  • 肥満と代謝障害
  • その他

スマートピルズのドラッグデリバリー市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024年)

主要企業プロファイル

  • Medtronic plc
  • Olympus Corp
  • Philips NV
  • CapsoVision Inc.
  • Jinshan Science & Tech
  • Check-Cap Ltd.
  • etectRx Inc.
  • Otsuka Pharmaceutical Co.
  • HQ Inc.
  • IntroMedic Co.
  • BodyCap Medical
  • Proteus Digital Health
  • RF Tracking Systems
  • AnX Robotica
  • Chongqing Science & Tech
  • Karl Storz SE & Co. KG
  • Fujifilm Holdings Corp
  • Boston Scientific Corp

結論と提言

目次
Product Code: SQMIG35A3073

Global Smart Pills Drug Delivery Market size was valued at USD 2.1 billion in 2023 and is poised to grow from USD 2.32 billion in 2024 to USD 5.16 billion by 2032, growing at a CAGR of 10.5% during the forecast period (2025-2032).

The smart pills drug delivery market is experiencing growth driven by the rising prevalence of gastrointestinal and chronic diseases, such as colorectal cancer and diabetes, which require continuous monitoring and treatment. Patients are increasingly favoring less invasive diagnostic methods, making smart pills an attractive alternative to traditional options. Innovations in endoscopic technology, including high-definition imaging and wireless data transmission, have enhanced the performance of these ingestible devices. Additionally, the shift towards remote patient monitoring supports the demand for smart pills, offering effective tracking of compliance and vital signs to improve clinical outcomes. However, challenges such as high device costs, limited reimbursement, regulatory hurdles, and concerns regarding data security and device reliability may hinder market adoption, particularly for long-term applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills Drug Delivery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Drug Delivery Market Segments Analysis

Global Smart Pills Drug Delivery Market is segmented by Type, Component, Application, End User, Disease Indication and region. Based on Type, the market is segmented into Capsule Endoscopy, Patient Monitoring Smart Pills and Drug-Delivery Smart Pills. Based on Component, the market is segmented into Ingestible Sensor, Wearable Receiver/Patch and Software & Analytics Platform. Based on Application, the market is segmented into Diagnostic Imaging, Medication Adherence Tracking and Targeted Drug Delivery. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, Home Healthcare and Research Institutes. Based on Disease Indication, the market is segmented into Gastro-intestinal Disorders, Oncology, Obesity & Metabolic Disorders and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Pills Drug Delivery Market

The increasing incidence of gastrointestinal disorders, including Crohn's disease, colorectal cancer, and chronic illnesses like diabetes, significantly boosts the demand for smart pills in the drug delivery market. These medical conditions require consistent monitoring and precise diagnostics, positioning smart pills as crucial tools for early detection and targeted drug administration. Their ability to facilitate site-specific drug delivery and improve long-term management makes them essential in tackling these health challenges. Consequently, the need for innovative healthcare solutions drives the expansion of the global smart pills drug delivery market, as they enhance treatment efficacy and patient outcomes.

Restraints in the Global Smart Pills Drug Delivery Market

The Global Smart Pills Drug Delivery market faces significant challenges due to the high costs associated with these advanced technologies, limiting accessibility for numerous patients and healthcare providers. The elevated expenses related to manufacturing and implementation hinder hospitals, especially those operating under budget constraints, from adopting smart pill technologies. Additionally, the lack of comprehensive insurance coverage exacerbates these financial barriers, preventing widespread integration of smart pills into healthcare systems. Consequently, the combination of high costs and limited insurance support poses a considerable obstacle to the large-scale adoption of this innovative drug delivery method.

Market Trends of the Global Smart Pills Drug Delivery Market

The Global Smart Pills Drug Delivery market is poised for significant growth, driven by the integration of AI technologies into future smart pills. These AI-enhanced capsules will enable real-time data analysis, facilitating early detection of health anomalies and personalized medication schedules tailored to individual patient needs. The seamless connectivity with electronic health records will further enhance patient management, positioning smart pills as critical tools in the shift towards predictive and precision medicine. This evolution not only promises to improve chronic disease management and diagnostics but is also expected to expand market opportunities, paving the way for innovative healthcare solutions that prioritize personalized patient outcomes.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Case Studies

Global Smart Pills Drug Delivery Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Capsule Endoscopy
  • Patient Monitoring Smart Pills
  • Drug-Delivery Smart Pills

Global Smart Pills Drug Delivery Market Size by Component & CAGR (2025-2032)

  • Market Overview
  • Ingestible Sensor
  • Wearable Receiver/Patch
  • Software & Analytics Platform

Global Smart Pills Drug Delivery Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Diagnostic Imaging
  • Medication Adherence Tracking
  • Targeted Drug Delivery

Global Smart Pills Drug Delivery Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals & Clinics
  • Diagnostic Centers
  • Home Healthcare
  • Research Institutes

Global Smart Pills Drug Delivery Market Size by Disease Indication & CAGR (2025-2032)

  • Market Overview
  • Gastro-intestinal Disorders
  • Oncology
  • Obesity & Metabolic Disorders
  • Others

Global Smart Pills Drug Delivery Market Size & CAGR (2025-2032)

  • North America (Type, Component, Application, End User, Disease Indication)
    • US
    • Canada
  • Europe (Type, Component, Application, End User, Disease Indication)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Component, Application, End User, Disease Indication)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Component, Application, End User, Disease Indication)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Component, Application, End User, Disease Indication)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corp
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips NV
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CapsoVision Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jinshan Science & Tech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Check-Cap Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • etectRx Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Otsuka Pharmaceutical Co.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HQ Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IntroMedic Co.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BodyCap Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteus Digital Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RF Tracking Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AnX Robotica
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chongqing Science & Tech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Karl Storz SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corp
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corp
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations